Keros Therapeutics
KROS
#8938
Rank
A$0.30 B
Marketcap
A$15.37
Share price
0.73%
Change (1 day)
-34.21%
Change (1 year)

Keros Therapeutics (KROS) Fails to deliver data

Key failure to deliver metrics for Keros Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Keros Therapeutics (KROS) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Keros Therapeutics (KROS) - since 2020

Volume in USD (price x number of shares), data since 2020

Keros Therapeutics (KROS) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026A$1.17 M-94.15%
2025A$20.15 M131.46%
2024A$8.7 M30.99%
2023A$6.64 M3.04%
2022A$6.45 M-72.87%
2021A$23.77 M128.32%
2020A$10.41 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
ORIC Pharmaceuticals
ORIC
A$6.67 MA$24.28 M๐Ÿ‡บ๐Ÿ‡ธ USA